July 17, 2023
A federal judge in New Jersey has signed off on a deal to end a coverage dispute between an Allianz unit and Bausch Health Cos. over whether the health company is entitled to coverage in class actions alleging an insider-trading scheme relating to a failed deal to take over pharmaceutical company Allergan PLC.
January 06, 2023
An Allianz unit can't yet ask the Third Circuit to weigh in on whether Bausch Health Cos. is entitled to coverage for class actions over an alleged insider trading scheme connected to its failed takeover of Allergan, a New Jersey federal court said.
September 06, 2022
Bausch Health Cos. received a win in its spat with insurers over coverage for class action suits the company faced in connection with its failed takeover of Allergan, with a New Jersey federal judge finding that the underlying actions count as covered "securities claims."
July 01, 2020
Insurers for Bausch Health Cos. asked a New Jersey federal judge Wednesday to find that they don't have to pay the pharmaceutical company's costs to defend and settle class-action suits it faced over an alleged insider trading scheme connected to a failed takeover of Allergan, contending the suits are not covered "securities claims."
April 24, 2020
Bausch Health Cos. asked a New Jersey federal judge on Thursday to declare that claims it faced over an alleged insider trading scheme connected to a failed takeover of Allergan were covered by the company's insurance policies.
January 12, 2018
Valeant Pharmaceuticals has sued an AIG unit and other insurers, seeking coverage of its costs to defend lawsuits accusing it of orchestrating an insider trading scheme in connection with its attempted $55 billion takeover of Allergan and of fraudulently inflating its stock price, court documents filed Friday in New Jersey federal court show.